These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3281 related items for PubMed ID: 22521771

  • 1. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [Abstract] [Full Text] [Related]

  • 2. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [Abstract] [Full Text] [Related]

  • 4. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M, French Collaborative National Database on UUT-UC.
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [Abstract] [Full Text] [Related]

  • 5. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 6. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Liu Y, Lu J, Hong K, Huang Y, Ma L.
    Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
    [Abstract] [Full Text] [Related]

  • 7. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
    Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE.
    Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
    [Abstract] [Full Text] [Related]

  • 8. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF.
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [Abstract] [Full Text] [Related]

  • 9. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS, Badalato GM, Hruby GW, Razmjoo M, McKiernan JM.
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [Abstract] [Full Text] [Related]

  • 10. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA, Krane LS, Hemal AK.
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration.
    Cancer; 2009 Mar 15; 115(6):1224-33. PubMed ID: 19156917
    [Abstract] [Full Text] [Related]

  • 12. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.
    Eur Urol; 2012 Apr 15; 61(4):818-25. PubMed ID: 22284969
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S, Mita K, Shigeta M, Usui T.
    Jpn J Clin Oncol; 2007 Apr 15; 37(4):296-301. PubMed ID: 17513309
    [Abstract] [Full Text] [Related]

  • 14. Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
    Youssef RF, Shariat SF, Lotan Y, Cost N, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Chromecki TF, Montorsi F, Bolenz C, Margulis V.
    Urol Oncol; 2013 Jul 15; 31(5):676-81. PubMed ID: 21704538
    [Abstract] [Full Text] [Related]

  • 15. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.
    BJU Int; 2012 Jul 15; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [Abstract] [Full Text] [Related]

  • 16. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
    Novara G, De Marco V, Gottardo F, Dalpiaz O, Bouygues V, Galfano A, Martignoni G, Patard JJ, Artibani W, Ficarra V.
    Cancer; 2007 Oct 15; 110(8):1715-22. PubMed ID: 17724728
    [Abstract] [Full Text] [Related]

  • 17. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
    Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF.
    Eur Urol; 2012 Feb 15; 61(2):245-53. PubMed ID: 21975249
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N, Kikuchi E, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakamura S, Oya M.
    BJU Int; 2013 May 15; 111(6):857-64. PubMed ID: 22757942
    [Abstract] [Full Text] [Related]

  • 19. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
    Gakis G, Fritsche HM, Hassan F, Kluth L, Miller F, Soave A, Otto W, Schwentner C, Todenhöfer T, Dahlem R, Burger M, Fisch M, Stenzl A, Aziz A, Rink M.
    Eur J Cancer; 2014 Oct 15; 50(15):2583-91. PubMed ID: 25088206
    [Abstract] [Full Text] [Related]

  • 20. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
    Wheat JC, Weizer AZ, Wolf JS, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ, Shariat SF.
    Urol Oncol; 2012 Oct 15; 30(3):252-8. PubMed ID: 20451416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 165.